Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services
Tóm tắt
Từ khóa
Tài liệu tham khảo
Coscia LA, 2009, Report from the National Transplantation Pregnancy Registry (NTPR): Outcomes of pregnancy after transplantation, Clin Transpl, 103
Roche Laboratories U.2007. Important changes in the CellCept [mycophenolate mofetil] prescribing information. Use of CellCept is associated with increased pregnancy loss and congenital malformations/change from pregnancy category C to pregnancy category D. Available at:http://www.fda.gov/downloads/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/UCM154077.pdf.